AJ Advisors LLC Buys 27 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

AJ Advisors LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 660 shares of the healthcare conglomerate’s stock after purchasing an additional 27 shares during the quarter. UnitedHealth Group makes up approximately 0.2% of AJ Advisors LLC’s holdings, making the stock its 27th biggest holding. AJ Advisors LLC’s holdings in UnitedHealth Group were worth $334,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $27,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the 4th quarter valued at $30,000. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the third quarter worth $32,000. Quarry LP boosted its holdings in UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 37 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group during the 3rd quarter valued at about $37,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

NYSE:UNH opened at $542.30 on Friday. The stock has a market capitalization of $499.07 billion, a PE ratio of 34.99, a P/E/G ratio of 1.46 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $536.17 and a 200 day simple moving average of $565.14. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter last year, the company posted $5.83 earnings per share. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.64 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Analyst Ratings Changes

A number of analysts have commented on UNH shares. Bank of America lowered their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. TD Cowen increased their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Piper Sandler decreased their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.